Association between large vessel vasculitis and inflammatory bowel disease: a case-control study

Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort

The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding

Multireader assessment as an alternative to reference assessment to improve the detection of radiographic progression in a large longitudinal cohort of rheumatoid arthritis (ESPOIR)

Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes

B-cell depletion and repopulation in autoimmune diseases

BAFF and rheumatic autoimmune disorders: implications for disease management and therapy

Quality and impact of information about interventional rheumatology: a study in 119 patients undergoing fluoroscopy-guided procedures

Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis

Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis

Group B streptococcal arthritis

Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes

BAFF overexpression is associated with autoantibody production in autoimmune diseases

[What place for DNA microarray in inflammatory diseases?]

DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets

Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis

Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells

Second-line drugs used in recent-onset rheumatoid arthritis in Brittany (France)

Value of laboratory tests in early prediction of rheumatoid arthritis

Is hypocomplementemia useful for diagnosing or predicting extra-articular manifestations in patients with rheumatoid arthritis?

Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later

Phenotypic, transcriptomic, and spatial characterization of CD45RB(+) naïve mature B cells: Implications in Sjögren's disease

Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programme

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide

Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells

Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab)

Role of Toll-like receptors in primary Sjögren's syndrome with a special emphasis on B-cell maturation within exocrine tissues

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

Toll-like receptor 9 drives the maturation of B lymphocytes in the salivary glands of patients with Sjögren's syndrome

Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome

Memory B-cell aggregates in skin biopsy are diagnostic for primary Sjögren's syndrome

Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells

[B lymphocytes in Sjögren's syndrome]

BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome

Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome

The mosaic of B-cell subsets (with special emphasis on primary Sjögren's syndrome)

Polarization of B effector cells in Sjögren's syndrome

A conspicuous role for B cells In Sjögren's syndrome

BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome

Is B-cell the conductor of the lymphocyte orchestra in the salivary glands of patients with primary Sjögren's syndrome

Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome

Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica

Tocilizumab in recent polymyalgia rheumatica: how can we manage the interleukin-6 blockage?

BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome

Rituximab in rheumatic diseases

Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study

French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease

Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study

Incidence and nature of karate injuries

Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus